InChI=1S/C35H44N4O6/c1-20-15-21(2)24(5)45-32(41)18-30(25-11-13-27(40)14-12-25)38-34(43)31(17-26-19-36-29-10-8-7-9-28(26)29)39(6)35(44)23(4)37-33(42)22(3)16-20/h7-15,19,21-24,30-31,36,40H,16-18H2,1-6H3,(H,37,42)(H,38,43)/b20-15+/t21-,22+,23+,24-,30-,31-/m1/s1 |
NCRSWJPOFRASIF-HPUNWYTPSA-N |
C[C@H]1OC(=O)C[C@@H](NC(=O)[C@@H](Cc2c[nH]c3ccccc23)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)C\C(C)=C\[C@H]1C)c1ccc(O)cc1 |
|
Chondromyces crocatus
(NCBI:txid52)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
(via chondramide )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(4R,7R,10S,13S,15E,17R,18R)-4-(4-hydroxyphenyl)-7-(1H-indol-3-ylmethyl)-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadec-15-ene-2,6,9,12-tetrone
|
18855324
|
Reaxys Registry Number
|
Reaxys
|
7404126
|
Reaxys Registry Number
|
Reaxys
|
11722228
|
PubMed citation
|
Europe PMC
|
18624308
|
PubMed citation
|
Europe PMC
|
18624309
|
PubMed citation
|
Europe PMC
|
8557566
|
PubMed citation
|
Europe PMC
|
|